Publications by authors named "Jessica Y W Ma"

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss and dysfunction in the retinal pigment epithelium (RPE) with age is known to contribute to disease development. The aim of this study was to investigate how the C57BL/6J mouse RPE changes with age. RPE structure was found to change with age and eccentricity, with cell size increasing, nuclei lost, and tight junctions altered in the peripheral retina.

View Article and Find Full Text PDF
Article Synopsis
  • Age-related macular degeneration (AMD) causes significant vision loss in older adults, characterized by the build-up of drusen and pigment changes in the retina, leading to the death of crucial retinal cells in advanced stages.
  • The retinal pigment epithelium (RPE) plays a vital role in retinal health by supporting photoreceptors and regulating immune responses; its dysfunction leads to chronic inflammation and further degeneration in AMD.
  • This review examines the interactions between RPE dysfunction and immune cell activity in AMD and discusses potential therapeutic targets based on findings from both patients and preclinical studies.
View Article and Find Full Text PDF

Eye size is a key parameter of visual function, but the precise mechanisms of eye size control remain poorly understood. Here, we discovered that the lipogenic transcription factor sterol regulatory element-binding protein 2 (SREBP2) has an unanticipated function in the retinal pigment epithelium (RPE) to promote eye size in postnatal mice. SREBP2 transcriptionally represses low density lipoprotein receptor-related protein 2 (Lrp2), which has been shown to restrict eye overgrowth.

View Article and Find Full Text PDF

The tear film is a layer of body fluid that maintains the homeostasis of the ocular surface. The superior accessibility of tears and the presence of a high concentration of functional proteins make tears a potential medium for the discovery of non‑invasive biomarkers in ocular diseases. Recent advances in mass spectrometry (MS) have enabled determination of an in‑depth proteome profile, improved sensitivity, faster acquisition speed, proven variety of acquisition methods, and identification of disease biomarkers previously lacking in the field of ophthalmology.

View Article and Find Full Text PDF